Press Releases

@Pexels - photo by Pavel Danilyuk

17

Jan

2025

SAHPRA clarifies the benefits and risks of medroxyprogesterone acetate

Pretoria, 17 January 2025 – The South African Health Products Regulatory Authori...

Share

@Pexels

29

Nov

2024

SAHPRA Offices will be unavailable on 29 November 2024

Please note that SAHPRA Head Office, including Cape Town and Durban Regional Off...

Share

@Pexels

22

Nov

2024

SAHPRA office closure during the 2024 festive season

SAHPRA offices will be closed for the festive season from 12:00 on Tuesday, 24 D...

Share

@Pixabay

21

Nov

2024

SAHPRA recalls a batch of YAZ Plus contraceptives due to a quality issue

Pretoria, 21 November 2024 – The South African Health Products Regulatory Author...

Share

@SAHPRA

08

Nov

2024

SAHPRA’s position on GLP1 and GIP-GLP1 products that are compounded, substandard and falsified

Pretoria, 08 November 2024 –The South African Health Products Regulatory Authori...

Share

@Uppsala Monitoring Centre

07

Nov

2024

SAHPRA encourages the safe use of medicines and reporting of suspected side effects this #MedSafetyWeek

Pretoria, 07 November 2024 – The South African Health Products Regulatory Author...

Share

@SAHPRA

07

Oct

2024

South African and Australian health product regulators to share regulatory information and expertise

Pretoria, South Africa and Canberra, Australia, 07 October 2024 –The South Afric...

Share

Jakub Zerdzicki via Pexels

16

Sep

2024

SAHPRA attains clean audit outcome for the 2023/2024 financial year

Pretoria, 16 September 2024 –The South African Health Products Regulatory Author...

Share

WESTOCK via Adobe Stock

22

Jul

2024

SAHPRA dismisses unfounded misinformation campaign deliberately misrepresenting its draft B-BBEE Policy by some sectors of society and media organisations

Pretoria, 22 July 2024 –The South African Health Products Regulatory Authority (...

Share

@SAHPRA

24

Jun

2024

SAHPRA CEO delivers keynote address at 2024 SAAPI Conference

The South African Association of Pharmacists in Industry (SAAPI) held its 2024 c...

Share

tibor13 via Adobe Stock

05

Jun

2024

SAHPRA releases results of investigation following recall of Benylin Paediatric syrup

Pretoria, 05 June 2024 –On 13 April 2024, the South African Health Products Regu...

Share

@SAHPRA

28

May

2024

SAHPRA attains ISO 9001 Certification as confirmation of its robust quality management processes

Pretoria, 29 May 2024 –The South African Health Products Regulatory Authority (S...

Share

@SAHPRA

28

Apr

2024

SAHPRA and Botswana Medicines Authority partner to enhance medicines regulation in the region

Pretoria, South Africa, 28 April 2024 – The South African Health Products Regula...

Share

@ Image by Steffen Frank on Pixabay

13

Apr

2024

SAHPRA recalls two batches of Benylin Paediatric Syrup

Pretoria, 13 April 2024 – On 10 April 2024, the South African Health Products Re...

Share

Photo courtesy of Rwanda FDA

12

Apr

2024

SAHPRA signs MoU with Rwanda Food and Drug Authority

Kigali – Rwanda, 12 April 2024 – The South African Health Products Regulat...

Share

olia danilevich via Pexels

04

Apr

2024

SAHPRA invests in patient safety – announcing new graduates

The South Africa Health Products Regulatory Authority (SAHPRA), in collaboration...

Share

WESTOCK via Adobe Stock

11

Mar

2024

Pretoria High Court Judgement on COVID-19 Vaccinations

Pretoria, 11 March 2024 – On 05 January 2023, the COVID Care Alliance NPC and ot...

Share

Safety of the COVID-19 Vaccine Janssen – response to restrictions imposed in the US- Image sourced from Pixabay/Pexels

torstensimon via Pixabay

19

Feb

2024

Department Dismisses Social Media Video on Covid-19 Vaccine Deaths

Pretoria, 19 February 2024 – The Department of Health has noted a misleading voi...

Share

Cytonn Photography via Pexels

12

Jan

2024

SAHPRA signs MoU with Medicines Control Authority of Zimbabwe

Pretoria, 12 January 2024 – The South African Health Products Regulatory Authori...

Share

Andrey Cherkasov via Adobe Stock

20

Dec

2023

SAHPRA recalls Lubri-A, sterile lubricating gel

Pretoria, 19 December 2023 – The South African Health Products Regulatory Author...

Share

PRESS RELEASES

SAHPRA clarifies the benefits and risks of medroxyprogesterone acetate

SAHPRA Offices will be unavailable on 29 November 2024

SAHPRA office closure during the 2024 festive season

SAHPRA recalls a batch of YAZ Plus contraceptives due to a quality issue

SAHPRA’s position on GLP1 and GIP-GLP1 products that are compounded, substandard and falsified

SAHPRA encourages the safe use of medicines and reporting of suspected side effects this #MedSafetyWeek

South African and Australian health product regulators to share regulatory information and expertise

SAHPRA attains clean audit outcome for the 2023/2024 financial year

SAHPRA dismisses unfounded misinformation campaign deliberately misrepresenting its draft B-BBEE Policy by some sectors of society and media organisations

SAHPRA CEO delivers keynote address at 2024 SAAPI Conference

SAHPRA releases results of investigation following recall of Benylin Paediatric syrup

SAHPRA attains ISO 9001 Certification as confirmation of its robust quality management processes

SAHPRA and Botswana Medicines Authority partner to enhance medicines regulation in the region

SAHPRA recalls two batches of Benylin Paediatric Syrup

SAHPRA signs MoU with Rwanda Food and Drug Authority

SAHPRA invests in patient safety – announcing new graduates

Pretoria High Court Judgement on COVID-19 Vaccinations

Department Dismisses Social Media Video on Covid-19 Vaccine Deaths

SAHPRA signs MoU with Medicines Control Authority of Zimbabwe

SAHPRA recalls Lubri-A, sterile lubricating gel

Contact us

Quick Menu

I want to..

Subscribe

Follow us |